What to expect when you take Carboplatin and have Deafness?

Do you take Carboplatin and have Deafness? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Aug, 15, 2018

8,903 reports have been studied.


Females aged 50 to 59 :

5,669 related reports were analyzed:

Most common symptoms:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  • 7.36% for females aged 50 (±5) who take Carboplatin
Anaemia (lack of blood)
  • 7.37% for females aged 50 (±5) who take Carboplatin
Dehydration (dryness resulting from the removal of water)
  • 5.8% for females aged 50 (±5) who take Carboplatin
Diarrhea
  • 5.73% for females aged 50 (±5) who take Carboplatin
Dyspnea (difficult or laboured breathing)
  • 8.08% for females aged 50 (±5) who take Carboplatin
Fatigue (feeling of tiredness)
  • 5.98% for females aged 50 (±5) who take Carboplatin
Fever
  • 7.0% for females aged 50 (±5) who take Carboplatin
Nausea (feeling of having an urge to vomit)
  • 11.25% for females aged 50 (±5) who take Carboplatin
Rashes (redness)
  • 6.24% for females aged 50 (±5) who take Carboplatin
Thrombocytopenia (decrease of platelets in blood)
  • 9.6% for females aged 50 (±5) who take Carboplatin

Most common co-existing conditions:

Breast cancer
  • 12.17% for females aged 50 (±5) who take Carboplatin
Ovarian cancer (cancer of ovary)
  • 16.74% for females aged 50 (±5) who take Carboplatin
back to top

Males aged 50 to 59 :

3,234 related reports were analyzed:

Most common symptoms:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  • 7.02% for males aged 50 (±5) who take Carboplatin
Anaemia (lack of blood)
  • 5.5% for males aged 50 (±5) who take Carboplatin
Dehydration (dryness resulting from the removal of water)
  • 6.34% for males aged 50 (±5) who take Carboplatin
Dyspnea (difficult or laboured breathing)
  • 7.33% for males aged 50 (±5) who take Carboplatin
Fever
  • 6.68% for males aged 50 (±5) who take Carboplatin
Nausea (feeling of having an urge to vomit)
  • 6.96% for males aged 50 (±5) who take Carboplatin
Pneumonia
  • 6.37% for males aged 50 (±5) who take Carboplatin
Thrombocytopenia (decrease of platelets in blood)
  • 7.76% for males aged 50 (±5) who take Carboplatin

Most common co-existing conditions:

Lung neoplasm malignant (cancer tumour of lung)
  • 7.54% for males aged 50 (±5) who take Carboplatin
Pain
  • 5.38% for males aged 50 (±5) who take Carboplatin
back to top

Related studies

carboplatin

Carboplatin has active ingredients of carboplatin. It is often used in cancer. (latest outcomes from Carboplatin 47,324 users)

deafness

Deafness has been reported by people with osteoporosis, rheumatoid arthritis, high blood pressure, multiple sclerosis, high blood cholesterol (latest reports from 13,838 Deafness patients).

Carboplatin and Deafness

Related publications that referenced our studies


Analysis tools (to study 499 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Carboplatin, Deafness

Recent updates

General studies
Active Support Groups
Recent Care Guides

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.